Document is current
Any future updates will be listed below
-
Authors
Paglicci, L.
Borgo, V.
Lanzarone, N.
Fabbiani, M.
Cassol, C.
Cusi, MG.
Valassina, M.
Scolletta, S.
Bargagli, E.
Marchetti, L.
Paladini, P.
Luzzi, L.
Fossi, A.
Bennett, D.
Montagnani, F. https://orcid.org/0000-0002-2267-1337
-
Funding
Funding for this research was provided by:
Università degli Studi di Siena
- License Information
-
More Information
Article History
Received: 1 July 2020
Accepted: 6 January 2021
First Online: 21 January 2021
Compliance with ethical standards
:
: MF received speakers’ honoraria and support for travel to meetings from Bristol-Myers Squibb (BMS), Gilead, Janssen-Cilag, Merck Sharp & Dohme (MSD), ViiV Healtcare, and fees for attending advisory boards from BMS, Gilead and Janssen-Cilag. FM received support for travel to meetings from Angelini, she is the principal investigator in a study sponsored by TLS (Toscana Life Science) and by GSK Vaccine SRL and she is the contact person for a service contract between GSK Vaccine SRL and Department of Medical Biotechnologies, University of Siena, without receiving any personal remuneration. All the other authors have no conflicts to declare.
: The study was approved by the local ethics committee (Azienda Ospedaliera Universitaria Senese, protocol OSS_REOS n° 12908).
